Novartis Slumps, Rubis Gains, Computacenter Up | Stock Movers
Community Score: 50% | 24 views | 1mo
0 community ratings: null thumbs up, null thumbs down
Today's biggest winners and losers in the stock market. On this episode of Stock Movers: - Novartis suffered its third clinical-trial setback in a week after a treatment for a rare muscle-wasting disease failed a late-stage study. Novartis shares plunged as much as 10% in early Zurich trading, reducing their gain for the year to about 4%, trailing rival Roche. - Computacenter shares climb as much as 7.4%, reaching a record high, after the IT services company upgraded its profit before tax guidance for fiscal year 2026 once again, after doing so at its July trading update. The group also reported a revenue beat in the first half, driven by strong AI-related spend in the US. - Rubis shares rise as much as 5.3% after the energy solutions firm boosted its Ebitda guidance for the full year. See omnystudio.com/listener (https://omnystudio.com/listener) for privacy information. Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the
Tags: Business, Business News, Daily News, News, bloomberg, bloomberg news, business, finance, investing, investing news, markets, markets news, podcast, radio, stock, stock market, stocks, stocks podcast
More from Bloomberg Podcasts
- Follow the Money All the Way to Carney's Canada — Score: 50%
- Daybreak Weekend: US CPI, Europe Energy, RBA Decision | Bloomberg Daybreak: Europe Edition — Score: 50%
- Bloomberg Money: Credit Card Indicators and Golf's Changing Fanbase | Bloomberg Intelligence — Score: 50%
- We hear you! | Bloomberg Hot Pursuit! — Score: 50%
- Bloomberg Businessweek Weekend - August 7th, 2026 | Bloomberg Businessweek — Score: 50%
- Team Favorite: AI-Era Internet, Spaceport Investment, Bolivia’s Investability | Wall Street Week — Score: 50%